RAYONT INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 USD | +19,900.00% |
|
-.--% | -.--% |
| 2023 | Rayont Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 | CI |
| 2023 | Rayont Inc. Announces Board Appointments | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Rayont Inc. operates in the personalized natural healthcare sector in United States and Australia. The Company uses scientific tools, such as deoxyribonucleic acid (DNA), microbiome, iridology and other tests to diagnose and personalize the prescription of natural complementary medicine products, services and treatments to its patients in the markets the Company operate. The Company produces a range of products, including proteins, green blends, sports nutrition, weight management and maintenance, and health and wellness products. The Company's subsidiaries include Rayont (Malaysia) Sdn Bhd, Rayont International (L) Limited, Rayont (Australia) Pty Ltd and Prema Life (USA) Inc.
Calendar
2024-10-13
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 4.57M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
- Stock Market
- Equities
- RAYT Stock
- News Rayont Inc.
- Rayont : Earnings Flash (RAYT) RAYONT Reports Q4 Revenue $457,865
